Jae Kim
Net worth: - $ as of 2026-05-30
Net worth: - $ as of 2026-05-30
Jae B. Kim worked as Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc. from 2016 to 2020.
Served as Chief Medical Officer at Avidity Biosciences, Inc. from 2020 to 2021.
Held the position of Chief Medical Officer at Design Therapeutics, Inc. from 2022 to 2024.
Worked as Chief Medical Officer at Septerna, Inc. from 2024 to 2026.
Completed undergraduate studies at Cornell University.
Earned a doctorate from Weill Cornell Medical College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SEPTERNA, INC. -.--% | 2026-02-05 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | End |
|---|---|---|
| SEPTERNA, INC. | Chief Tech/Sci/R&D Officer | 2026-05-10 |
| DESIGN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-08-31 |
| AVIDITY BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-08-29 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-06-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Avidity Biosciences, Inc.
Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Design Therapeutics, Inc.
Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
Septerna, Inc.
Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
Select your edition
All financial news and data tailored to specific country editions